Latest News in the pharma Industry
Top Stories
BMS strengthens capabilities with evolution of its US geographic footprint
13 Dec 2016
Company will also close its Hopewell, New Jersey site and will not renew its lease at the Lake Union Steam Plant site in Seattle, Washington.
Read more
Pfizer refutes the findings set out in the CMA decision
8 Dec 2016
Pharma giant says it complied with established competition law.
Read more
Hopes dashed for new Alzheimer drug
23 Nov 2016
Lilly's solanezumab fails to meet primary endpoint of Phase III study.
Read more
Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor
2 Nov 2016
Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders.
Read more
Fighting cancer with the power of immunity
24 Oct 2016
New treatment elicits two-pronged immune response that destroys tumors in mice.
Read more
Pfizer announces US availability of biosimilar Inflectra
21 Oct 2016
Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US.
Read more
Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector
10 Oct 2016
The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel.
Read more
Pfizer decides to remain as one company
26 Sep 2016
Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility.
Read more
Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance
25 Sep 2016
Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance.
Read more
GSK announces significant new investment in UK manufacturing network
27 Jul 2016
Investment in advanced manufacturing of new respiratory and biopharmaceuticals portfolio.
Read more
BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer
27 Jun 2016
This milestone marks the sixth Breakthrough Therapy Designation for Opdivo.
Read more
Shire completes combination with Baxalta
3 Jun 2016
Combined company expected to deliver double-digit compound annual top-line growth with over $20 billion in annual revenues by 2020.
Read more